National Institutes of Health logo
National Institutes of Health

Illuminating AD/ADRD Genome to Enable Precision Genomic Medicine

Funds cross-ancestry, cross-species genomic studies of Alzheimer's disease and related dementias, aimed at therapeutic targets for precision medicine.

Alzheimer's disease and related dementias have genomic drivers that differ across populations and across related neurodegenerative diseases, and studying any one ancestry or one disease in isolation risks missing what is actually general versus what is specific.

This notice funds integrative, cross-disciplinary projects that scale up mechanistic study of those genomic drivers, using tools like ge…

Integrative, cross-disciplinary projects using genome editing, functional characterisation, single-cell and spatial omics, machine learning and comparative genomic analysis across genetic ancestries, model organisms or neurodegenerative diseases, in stem-cell, ex vivo and in vivo disease models, to identify the genomic drivers of Alzheimer's disease and related dementias and their actionable therapeutic targets.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.One-off
Next deadlineiThe next date applications are due. Rolling means you can apply any time.-
Decision timeiTypical time from the deadline to the funder's decision.26 weeks
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Cooperative agreement
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.-
Funding pooliThe total budget available across all awards in this round.-

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides β†’
National Institutes of Health logo
Open

GREGoRi Data Coordination and Outreach Center

πŸ‡ΊπŸ‡ΈNIH Β· United States

Funds the one centre that coordinates a rare-disease genomics programme and gets its protocols, data and tools out to everybody else.

BiotechAI
$1.3MOct'26
National Institutes of Health logo
Open

GREGoRi Innovation Projects

NIH Β· United States

Funds a genuinely new experimental or computational approach to finding the cause of a rare genetic disorder, where the current state of the art falls short.

BiotechAI
$3 – $500KOct'26
National Institutes of Health logo
Open

GREGoRi Technology Integration Center

πŸ‡ΊπŸ‡ΈNIH Β· United States

Funds the centre that turns new molecular methods for rare-disease diagnosis into standards, best practices and a benchmarking dataset.

BiotechAI
$2.3MOct'26
National Institutes of Health logo
Open

Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases

πŸ‡ΊπŸ‡ΈNIH Β· United States

Funds studies that watch patients rather than treat them, in bone, joint, rheumatic and skin disease. No intervention allowed.

Medtech
Nov'26
National Institutes of Health logo
Open

Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61)

πŸ‡ΊπŸ‡ΈNIH Β· United States

Funds early-stage clinical trials in arthritis, musculoskeletal and skin disease. A trial is compulsory.

MedtechBiotech
Nov'26
National Institutes of Health logo
Open

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01)

NIH Β· United States

Funds theory and method development on how genetic and non-genetic factors together produce variation in complex traits, tested against large existing datasets.

BiotechAI
Nov'26